Short description
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Description
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Heidelberg, Baden-Wurttemberg, Germany, Europe
Founded on
January 1, 2000
Exited on
September 12, 2014
Went public on
September 12, 2014
Stock symbol
AFMD
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Nopepepe, Noway Youcantaccess, Noaccessforu, Noaccess, Blurry Noaccess, Noaccess, Noaccess, Blurry Noaccess, Blurry Noaccess, No Way, Absolutely Noaccess
Sign in for full access
Founders
Melvyn Little